As of 2024-12-13, the Fair Value of Talaris Therapeutics Inc (TALS) is -8.73 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.72 USD, the upside of Talaris Therapeutics Inc is -421.08%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | - | 5Y Avg | |
| Net income | -22.71 | -47.83 | -73.89 | - | -48.15 | |
| YoY growth | -25.06% | -110.63% | -54.48% | - | -63.39% | |
| Market Cap (mil) | 116.44 |
| P/E | |
| Forward P/E |
| EPS | -1.75 |
| Avg earnings growth rate | -63.39% |
| TTM earnings | -74.77 |